In May 2021, a punch biopsy of the lesion was diagnostic for MS, with immunohistochemistry positive for CD117, cKit, CD4, CD56, CD33, PGM1, and Bcl2 and negative for CD34, MPO, CD20, CD3, CD23, Tdt, and CD79a. This evidence concerns the gene KIT and myeloid sarcoma.